← Back to Search

Adductor Canal Catheter for Total Knee Arthroplasty (ACCESS Trial)

N/A

Waitlist Available

Led By Adrian Hinman, MD

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14th postoperative day

Awards & highlights

ACCESS Trial Summary

This trial is testing whether or not a catheter containing ropivacaine placed in the adductor canal can reduce postoperative pain levels in patients undergoing elective primary unilateral total knee arthroplasty, as compared to usual care without the catheter.

ACCESS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ second postoperative day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~second postoperative day

This trial's timeline: 3 weeks for screening, Varies for treatment, and second postoperative day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain Numerical Rating Scale

Secondary outcome measures

Knee Injury and Osteoarthritis Outcomes Score (KOOS) Jr

ACCESS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: DeviceExperimental Treatment1 Intervention

Placement of an adductor canal catheter

Group II: No-DeviceActive Control1 Intervention

No placement of an adductor canal catheter

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Adductor Canal Catheter

2021

N/A

~130

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor

537 Previous Clinical Trials

24,113,573 Total Patients Enrolled

Adrian Hinman, MDPrincipal InvestigatorKaiser Permanente

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this research protocol for participants?

"As per clinicaltrials.gov, this medical experiment is presently in search of participants and has been active since March 15th 2021 with the most recent edit occuring on November 4th 2022."

Answered by AI

How many subjects are taking part in this research endeavor?

"Affirmative. Clinicaltrials.gov confirms that this research initiative, which was first advertised on March 15th 2021, is currently recruiting participants. 118 people need to be selected from 1 site for the study to move forward."

Answered by AI

Recent research and studies

International OrthopaedicsJournal

Peri-articular Injections of Local Anaesthesia Can Replace Patient-controlled Analgesia After Total Knee Arthroplasty: A Randomised Controlled Study

Song, Moo-Ho, Bu-Hwan Kim, Seong-Jun Ahn, Seong-Ho Yoo, Suk-Woong Kang, Yeong-Joon Kim, and Dong-Hwan Kim. 2015. “Peri-articular Injections of Local Anaesthesia Can Replace Patient-controlled Analgesia After Total Knee Arthroplasty: A Randomised Controlled Study”. International Orthopaedics. Springer Science and Business Media LLC. doi:10.1007/s00264-015-2940-2.

Regional Anesthesia and Pain MedicineJournal

Feasibility and Efficacy of Ultrasound-guided Block of the Saphenous Nerve in the Adductor Canal

Manickam, Baskar, Anahi Perlas, Edel Duggan, Richard Brull, Vincent W.S. Chan, and Reva Ramlogan. 2009. “Feasibility and Efficacy of Ultrasound-guided Block of the Saphenous Nerve in the Adductor Canal”. Regional Anesthesia and Pain Medicine. BMJ. doi:10.1097/aap.0b013e3181bfbf84.

versusJournal

Adductor Canal Block<i>versus</i>femoral Nerve Block for Total Knee Arthroplasty

Kim, David H., Yi Lin, Enrique A. Goytizolo, Richard L. Kahn, Daniel B. Maalouf, Asha Manohar, Minda L. Patt, et al.. 2014. “Adductor Canal Blockversusfemoral Nerve Block for Total Knee Arthroplasty”. Anesthesiology. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/aln.0000000000000119.

clinicaltrials.govStudy